Menu

NSE

Raymond Realty Demerger Completed, Shareholders to Receive Shares on 1:1 Basis
Market News - May 12, 2025

Raymond Realty Demerger Completed, Shareholders to Receive Shares on 1:1 Basis

Raymond Realty Demerger Completed, Shareholders to Receive Shares on 1:1 Basis

 

Raymond spins off its real estate arm, offering shareholders a 1:1 share allotment in the newly listed Raymond Realty Limited. Record date set for May 14, 2025, as the group sharpens its business focus.

Major Milestone: Demerger Becomes Effective

Earlier this year, the National Company Law Tribunal (NCLT) gave the green light to the long-awaited separation of Raymond’s real estate arm.
The demerger became operational on May 1, 2025, following the board’s resolution and regulatory filings. This marks a significant restructuring for Raymond, a brand synonymous with India’s lifestyle and textile sectors, as it continues to streamline its corporate structure for sharper business focus.

What the Demerger Means for Shareholders

According to the approved Scheme of Arrangement, shareholders of Raymond Limited (RL) will receive one share of Raymond Realty Limited (RRL) for each share they own in RL, based on a direct 1:1 exchange ratio.
There are no additional costs or actions required from shareholders. The record date to determine eligibility for this share allotment is Wednesday, May 14, 2025.
This implies that all investors owning Raymond shares at the end of that day will automatically receive an equivalent number of shares in the newly separated Raymond Realty.

Raymond Realty: A Standalone Growth Story

Raymond Realty, once a division within the parent company, is now a fully independent, listed entity. The move allows the real estate arm to pursue its own strategy, leadership, and capital allocation, much like recent demergers seen in other Indian conglomerates.
Raymond Realty has established a strong presence in Mumbai’s residential market, with luxury projects in Thane and joint development agreements in key city locations such as Bandra, Mahim, Sion, and Wadala. In the last financial year, the company reported revenues of ₹15.9 billion and an EBITDA of ₹3.7 billion, highlighting its operational strength and future potential.
The company’s aggressive expansion in the Mumbai Metropolitan Region, including six major joint development agreements, positions it as a significant player in India’s booming real estate sector.

Strategic Rationale: Focus, Agility, and Value Creation

This demerger is part of a broader trend among Indian corporates to unlock value by spinning off high-growth verticals into standalone companies. Through the separation of its real estate division, Raymond intends to:
• Enhance operational focus for both businesses
• Enable agile, sector-specific decision-making
• Attract targeted investment and strategic partnerships
• Maximize long-term shareholder value
The move follows Raymond’s earlier spin-off of its lifestyle and fashion business, which was also listed as a separate entity. The group’s restructuring strategy reflects a clear intent to sharpen its business focus and respond to evolving market opportunities.

What’s Next for Investors?

Shareholders should ensure their holdings are updated and dematerialized before the record date of May 14, 2025, to be eligible for the 1:1 share allotment in Raymond Realty. After the listing, investors will be able to trade Raymond Realty shares independently of Raymond Limited, providing flexibility and potential for value appreciation based on the real estate business’s performance.

Conclusion

Raymond’s demerger of its real estate arm is a landmark step in the group’s ongoing transformation. By granting shareholders a direct stake in Raymond Realty, the company is unlocking value and setting the stage for focused growth in both its core businesses. As Raymond Realty prepares for its debut on the stock exchanges, investors and market watchers alike will be keenly observing its next moves in India’s dynamic real estate sector.

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Fenesta Invests in DNV Global to Strengthen Industry Hold

, , , , , , , , , 0 Comment
Read More
 Dr. Reddy’s Laboratories Stock Slides Amid High Trading Volumes
Equities - May 8, 2025

 Dr. Reddy’s Laboratories Stock Slides Amid High Trading Volumes

Dr. Reddy’s Laboratories Stock Slides Amid High Trading Volumes

 

Amid increased investor activity and market uncertainty, Dr. Reddy’s faces pressure as its shares trend downward despite sound fundamentals.

Introduction

In early May 2025, Dr. Reddy’s Laboratories, one of India’s leading pharmaceutical firms, saw its share price retreat notably during high-volume trading sessions. The stock registered multiple days of decline, slipping close to ₹1,156 by May 6. Despite consistent earnings and a stable operational outlook, investors appear to be reacting to broader market forces and sectoral headwinds.
The sudden rise in trading activity alongside price depreciation has raised questions: Is this a short-term market overreaction, or a signal of deeper challenges?

Stock Performance Overview

Over the past week, Dr. Reddy’s stock has consistently traded in the red, marking a fall of nearly 2% in just one day, followed by successive dips. By May 6, the share was down 1.28%, closing at ₹1,156.50.
Interestingly, this drop coincided with unusually high trading volumes — a telltale sign of strong institutional or speculative activity. Such a pattern often suggests heightened investor sentiment, though not always driven by fundamental changes.

Technical Indicators Show Weak Momentum

Analysts have noted that Dr. Reddy’s shares are currently trading below several key moving averages — including the 5-day, 20-day, 50-day, 100-day, and 200-day marks. This trend typically indicates a bearish outlook in the short term and can prompt algorithmic and institutional traders to offload holdings, thereby accelerating the decline.
The company’s stock also appears to be underperforming the broader pharmaceutical index, a sector that itself is facing renewed pressure due to regulatory concerns, pricing fluctuations, and global competition.

Company Fundamentals Remain Strong

Despite the downward movement in share price, Dr. Reddy’s core financials remain healthy. The company has demonstrated consistent revenue growth over recent quarters, with a solid balance sheet and a competitive pipeline of generics and specialty drugs.
Its price-to-earnings (P/E) ratio, currently around 18.02, is significantly lower than the industry average, suggesting the stock may be undervalued relative to peers. This makes the recent downturn even more puzzling when viewed through the lens of strong business fundamentals.

Sectoral and Market Sentiment at Play

The broader pharmaceutical sector has been facing uncertainty, especially with increasing scrutiny on drug pricing, both domestically and in export markets like the US. In addition, currency fluctuations and raw material cost pressures have contributed to volatility.
Investors may also be taking a cautious stance amid upcoming regulatory updates or waiting on quarterly earnings from peer companies before recalibrating positions. Furthermore, large-cap pharma stocks like Dr. Reddy’s often serve as barometers for institutional investors who adjust allocations based on broader risk appetite.

Analyst and Investor Perspectives

While some analysts see this as a routine market correction, others suggest it could be a signal of shifting investor focus from defensives like pharmaceuticals to other emerging sectors, such as banking or capital goods, especially as interest rate expectations change.
There’s also speculation that part of the sell-off may be due to portfolio rebalancing by large funds at the start of the new fiscal quarter.
Nonetheless, retail investors are advised to remain cautious. For long-term holders, the current dip may offer an opportunity to accumulate at more attractive valuations, provided the fundamentals remain intact.

Conclusion

Dr. Reddy’s Laboratories is no stranger to market fluctuations, but the recent slide in its share price—despite no apparent deterioration in financial performance—highlights the complex interplay between technical, investor psychology, and sector-wide sentiment.
While the stock’s current trajectory may concern short-term traders, long-term investors might view this as a healthy correction or even a buying opportunity. As always, close monitoring of future earnings, regulatory updates, and global pharma trends will be crucial in determining the path ahead.

 

 

 

 

The image added is for representation purposes only

Disney Set to Absorb $300 Million Loss After India JV Overhaul with Reliance

, , , , , , , , , , 0 Comment
Read More
 Cellecor Gadgets’ Meteoric Rise: Retail Expansion Fuels 65% Share Surge in One Year
Equities - May 3, 2025

 Cellecor Gadgets’ Meteoric Rise: Retail Expansion Fuels 65% Share Surge in One Year

 Cellecor Gadgets’ Meteoric Rise: Retail Expansion Fuels 65% Share Surge in One Year

 

Small cap consumer electronics firm deepens market reach through new stores and partnerships, driving robust revenue growth and investor returns.

Retail Footprint Expansion Sparks Share Rally

On May 2, 2025, Cellecor Gadgets announced the launch of its eighth exclusive brand store in Barnala, Punjab—an aggressive push into one of India’s high potential appliance markets. The news sent the stock up nearly 3% intraday, with shares trading around ₹46.05, versus a prior close of ₹45.55.
Punjab’s appliance market, estimated at over USD 3.25 billion and representing some 4.2% of India’s total, offers fertile ground for growth as urbanisation and digital adoption climb. By establishing a dedicated retail outlet there, Cellecor aims to deliver hands on experience for its smart TVs, home appliances, and wearables—deepening customer engagement and brand trust.

Strategic Partnerships in South India

Earlier, on March 17, 2025, Cellecor announced tie ups with two major South Indian retail chains—B New Mobiles (141 stores across Andhra Pradesh and Telangana) and Celekt (117 stores across Andhra Pradesh, Telangana, and Maharashtra). This collaboration immediately lifted the stock over 7% in a single session, as investors cheered the company’s broader distribution network and potential ₹50 crore annual business from this partnership.
By leveraging established retail partners’ expertise and footprint, Cellecor gains instant access to millions of customers in key southern markets—further diversifying its geographic revenue streams and reducing customer acquisition costs.

Financial Performance and Future

Cellecor reported a staggering 105% year on year revenue increase to ₹1,025.95 crore in FY25, with net profit surging 92% to ₹30.90 crore. Riding this momentum, management has earmarked ₹100 crore for capacity expansion, R&D, and market outreach, aiming to add ₹500 crore in incremental sales and surpass ₹1,500 crore in revenue in FY26.

This robust financial trajectory underpins the stock’s appeal: from a 52 week low sub ₹20 level, Cellecor shares have rallied over 200% in the past year, delivering multibagger returns even as they remained under the ₹50 threshold for value investors.

  • Driving Factors Behind Growth
     Omni channel Approach: By combining exclusive brand stores with partnerships across independent retail chains, Cellecor ensures widespread product visibility, personalized demos, and after sales support—key differentiators in India’s competitive electronics market.
  •  Make in India Push: Investments in local manufacturing, OEM tie ups, and new warehousing infrastructures have improved margins and supply resilience, supporting the company’s cost leadership strategy.
  •  Diversified Product Mix: With over 600 SKUs spanning air conditioners, refrigerators, smartphones, laptops, and emerging categories like air fryers and microwaves, Cellecor mitigates concentration risk while capturing cross sell opportunities.
    4. Alternative Funding and Valuation: Trading under ₹50 yet commanding a market cap near ₹1,000 crore, the stock attracts both retail and institutional investors seeking high beta plays in India’s consumption story.

Analyst Perspectives and Risks
• Upside Potential: Brokerage reports highlight the ₹1,500 crore revenue target for FY26 as achievable, given current store roll outs and partnership deals. Some analysts project a 20–30% upside from current levels if execution remains on track.
• Execution Risk: Rapid expansion carries the risk of operational bottlenecks—inventory management, quality control, and after sales service consistency will be critical.
• Competitive Landscape: Established incumbents and global brands are also ramping up India focused launches. Cellecor must sustain innovation and cost advantages to protect its niche.

Conclusion

Cellecor Gadgets’ strategy of deepening its retail footprint—both through company owned stores and strategic alliances—has catalyzed a remarkable 65% share price gain in one year. Backed by robust financials, a diversified product lineup, and aggressive FY26 targets, the SME stock offers an intriguing blend of growth potential and value. However, investors should weigh execution and competitive risks as the company scales its omni channel model across India’s vast and varied markets.

 

 

 

 

The image added is for representation purposes only

April Sees Indian Manufacturing at Highest Level Since June 2024, Bolstered by Exports and Recruitment

, , , , , , , , , 0 Comment
Read More
Get Ready to Invest: Tata Capital's Game-Changing ₹15,000 Crore IPO!
Business, Equities, Market News, Markets - December 20, 2024

SME IPO Migration: Key Changes in SEBI Guidelines

SME IPO Migration: Key Changes in SEBI Guidelines

On 18th December 2024, the Securities and Exchange Board of India (SEBI) issued revised guidelines for Small and Medium Enterprises (SMEs) seeking to migrate from the SME platform to the mainboard of stock exchanges. These updated norms aim to ensure financial robustness and operational stability for companies making the transition. The guidelines apply to both BSE and NSE platforms and are as follows:

Migration to Mainboard
For SMEs to migrate to the BSE Mainboard, they must meet the following criteria:

  • Paid-up Capital: The company should have a paid-up capital exceeding ₹10 crores.
  • Market Capitalization: The company’s market capitalization must be at least ₹25 crores.
  • Net Worth: A minimum net worth of ₹15 crores for the two preceding full financial years is required.
  • Listing Duration: The company must have been listed on the SME platform of the Exchange for at least three years.
  • Positive EBITDA: The company should have posted a positive EBITDA for at least two out of the last three financial years.
  • Positive PAT: A positive Profit After Tax (PAT) in the immediate financial year of making the migration application is necessary.
    Migration to NSE Mainboard

For SMEs to migrate to the NSE Mainboard, the guidelines are slightly stricter, requiring:

  • Paid-up Capital: The company must have a paid-up capital of ₹10 crores or more.
  • Market Capitalization: A minimum market capitalization of ₹25 crores is mandatory.
  • Net Worth: The company should have a net worth of at least ₹75 crores.
  • Listing Duration: A listing period of three years on the SME platform is essential.
  • Positive EBITDA: A positive EBITDA from operations for each of the preceding three financial years is required.
  • Positive PAT: The company must show a positive PAT in the immediate financial year prior to applying for migration.

Disclaimer
These guidelines, issued on 18th December 2024, are subject to change at the discretion of the exchanges.

The revised criteria reinforce the importance of consistent financial performance and operational maturity for SMEs looking to scale up to the mainboard.

The image added is for representation purposes only

TCS Unveils Pace Studio in Philippines to Boost Digital Innovation

, , , 0 Comment
Read More
Equity Right
Editorials, Equities, Markets - July 27, 2022

Government allows Indian public companies to directly list shares overseas.

Government allows Indian public companies to directly list shares overseas.

 

Government’s vision for betterment of Indian companies:

In late January 2020 Government of India communicated to media that they are planning to allow direct listing of Indian companies in foreign markets. This will help Indian companies to not only rely on domestic markets but they can also raise capital on large scale from various foreign markets which will help companies in diversification and growth. This move can directly help Indian companies in increasing their turnover and profits.

Till now Indian companies go for the depository receipts to attract investors globally but this is bit unfamiliar amongst the investors globally and been less attractive in recent years. A minimum of 15 Indian companies currently attract foreign investors via ADR’s and GDR’s. These companies includes Reliance Industry, HDFC Bank, Infosys and many others.

 

Green signal by Indian Government:

Finance Minister Nirmala Sitharaman had announced an economic package of ₹ 20 lakh crore under government’s Atma Nirbhar Bharat Abhiyan. This is done for the revival of Indian Economy. It is an umbrella of massive ₹ 20 lakh crore economic booster package. The government ensured to provide some relaxation in all the sectors.

To improve “ease of doing business” in India, government allowed Indian public companies to list their shares in foreign markets. This provision will help Indian companies for better valuations, rapid growth and expand their businesses on a large scale. This move will help Indian companies to get funds at a cheaper rate from various foreign markets. This will directly help Indian economy to recuperate in a speedy way.

Government noted private companies that listed Non-convertible debentures (NCDs) on Indian stock exchanges not to be considered as listed companies. It is also expected that this provision is to prevent Indian companies to register themselves in foreign markets like Singapore and London for raising a fund and going global.

 

Existing vs proposed rule:

The existing rule states that companies which are listed on Indian stock markets can only list their company in foreign markets. Whereas, new proposed rule states that there is no compulsion for it. Indian companies can list themselves directly in various foreign markets to raise capital.

Until now, only American Depository Receipt (ADR’s) and Global Depository Receipt (GDR’s) can collect capital from foreign market sources. At least 15 Indian companies follow this mechanism to raise capital from foreign markets. However, this is not much familiar amongst the global investors. To eradicate this the new provision will allow Indian companies to a fresh new issue of shares or sale of existing holdings.

 

Rules and regulation:

All the required rules and regulation for listing an Indian company at abroad will be notified soon by the government. Once the provisions to the Foreign Exchange Management Act (FEMA) and Company Law Regulations are passed. Media noted Indian foreign exchange control laws do not require free capital convertibility, and there are other regulatory limits on capital account transactions.

Nevertheless, this proposal has been under discussion for a couple of years between stakeholders and regulators, especially regarding the selection of foreign jurisdiction. SEBI had indicated in 2018 that this route would be open only to the financially sound companies, so that the mechanism could not be used for exploitation. Sources indicated that final rules in this respect would probably be based on the Financial Action Task Force’s recommendations.

Finance Minister Nirmala Sitharaman noted, this provision of direct listing. If Indian public companies are not available over the globe but will be allowed in permissible jurisdictions.

 

Precautionary measures:

However, the approval will not come without any protections. The Indian government is likely to go along with the recommendations raised by SEBI in 2018. This requires a direct listing of Indian companies in abroad. It had suggested 10 overseas jurisdictions, including the US, UK, Japan, China, Hong Kong and South Korea for Indian companies to list. The selection was based on the fact that these jurisdictions are part of the Financial Action Task Force (FATF), The Anti-Money Laundering Global Task Force (GTF-AML) and IOSCO.

SEBI also suggested that this provision should be available only for financially stable . This will aid  to minimize frauds and manipulation. The firms with a  paid-up capital of 10% will be allowed to list in the foreign market.

The provision of capital raising in an overseas market can also have an impact on the Indian currency market. Since the flow of overseas capital can put pressure on the Indian currency and may lead to volatility. RBI and SEBI can be jointly involved to check this.

 

 

 

, , , , , , , 0 Comment
Read More
Equity Rght
Business, Market News, Markets - May 19, 2020

BSE, NSE cut listing fees for SMEs

BSE, NSE cut listing fees for SMEs

 

Due to COVID-19 pandemic, all the sectors have been affected badly but SMEs segments are affected the most. Therefore, during the announcements of details of Rs 20 lakh crore stimulus package, Finance minister Nirmala Sitharaman made special announcements related to MSMEs.

 

Reduction in listing fees:

Now to support SMEs and MSMEs, Indian stock exchanges BSE and NSE came forward. They have relaxed listing norms and reduced listing fee for small and medium enterprises by 25%. However, this norms are applicable to both existing and new firms which are looking forward to list on BSE SME platform and NSE SME platform.

 

What are the Current charges?

Currently for SMEs, Rs 25,000 or 0.1 percent of market capitalization of firm is the listing fee charged by BSE. The NSE charges around Rs 10,000 to Rs 45,000, depending on the SME firms market capitalization. Until now, BSE has 322 small and medium companies listed and has raised around Rs 3,278.84 crore from the market. Their market capitalisation is of Rs 15,865.39 crore so far. On the other side, so far only 209 small and medium companies are listed on NSE and have raised over Rs 3,200 crore.

 

What measures have been announced by government?

Due to the covid-19 lock down, many industries are facing problems like job losses and are cash strapped. During this situation, the main concern for MSMEs is that they are not able to restart their operations due to supply issues and non-availability of labour. Last week, while making announcement for packages in tranches, government changed the definition for MSMEs and linked it to the turnover limits of the companies so that their businesses grow with benefits. They announced measures for MSMEs and Rs 3 lakh crore package for collateral free automatic loans with separate funds for equity support.

However, these Rs 3 lakh crore will also be useful for existing borrowers who have over Rs 100 crore turnover and Rs 25 crore outstanding. Fresh loans can be taken by companies up to 20% of their outstanding. These loans have tenure of 4 years, with moratorium repayment period of 12 months. However, the government will also give them credit guarantee of 100 percent which will cover interest and principal to banking and non-banking institutions. Government will give around Rs 4,000 crore funds to Credit Guarantee Fund Trust for Micro and Small Enterprises (CGFTMSE) with partial credit guarantee to banks. However for expansion of MSMEs, the government will provide corpus of Rs 10,000 crore so that they can also list after expansion.

 

Further Expectations:

Micro, small and medium enterprises (MSMEs) are very cautious while taking any kind of fresh loans, as they are not sure about the demands for their products after all activity resumes. Most of the micro, small and medium businesses and enterprises are expecting from the government, to give them direct relief by waiving their electricity bills and other fixed expenditure such as payment of salaries. However, banks have already reduced their loans such as credit limit. Anil Bhardwaj, Secretary general of federation of Indian micro, small & medium enterprises (FISME) said, for all the small business and enterprises, government will take care of their fixed expenses. MSME industry has three major demand, interest payments, easy access to loans and payments of salaries from the government, during this situation due to COVID-19 lock down.

 

 

FPIs exit markets after economic package announcement.

, , 0 Comment
Read More
Weakest performance of Rupee at 87.21 against US dollar
Equities, Market News, Markets - May 9, 2020

BSE, NSE to launch rupee derivative contracts

BSE, NSE to launch rupee derivative contracts

 

The NSC IFSC  and India INX have introduced rupee derivatives which will help in bringing much needed added liquidity in the economy. This will supplement their customers with several investment options.

The motive behind introduction of rupee derivatives:

The CEO of NSE, Vikram Limaye communicated to the media that the introduction of rupee derivatives will help in the development of (Gujarat International finance tech) GIFT IFSC as a hub of global financial services. This IFSC platform will help in the rupee exposure of non resident participants. This non residents’ participation will also enhance the IFSC’s extended trading hours and USD settlement. They’ve already received permissions for offering securities trading in any currency except the Indian rupee.

 

Importance of introduction of rupee derivatives:

Mr. Limaye added that this measure will enhance the efficiency of Indian rupees’ price discovery. It will be done by eliminating the onshore and offshore markets’ segmentation. It will also allow for trading and hedging using rupee derivatives contracts to their trading partners viz. IFSC entities and banking units. The Finance Minister Nirmala Sitharaman did the inauguration of the rupee derivatives contract. The contract will be having a lot size in NSE IFSC – Rs 20 lacs and India INX – Rs 10 lacs and the contract will be settled in cash.

 

The futures and options:

The futures at the NSE IFSC will have in total three monthly expiry contracts . The options at NSE IFSC will have total seven weekly and three monthly expiry contracts. For the other one i.e India INX, there will be in total eleven weekly and twelve monthly contracts. In the past few months due to the corona virus pandemic crisis, there is an acute volatility faced by the currency markets. The introduction of rupee derivative contracts in the IFSC will lead to more stability during these situations.

 

The Contracts:

The chairman of India INX, Ashishkumar Chauhan communicated to the media that the size of contract will be Rs 10 lacs and the trading is made available from 8th May 2020, 3:30 pm IST. The trading is for both the pairs viz. USD-INR and INR-USD. He added that for the USD-INR product, many of the people like the exporters, importers, traders, etc associated with any kinds of businesses have expressed their keen interest. The Gandhinagar GIFT City is the only IFSC situated in India having zero short term, zero long-term, zero stamp duty and zero transaction taxes as of now.

Each and every businessman interested should consider trading and hedging using rupee derivatives contracts at the GIFT City. The MD and CEO of India INX, V Balasubramaniam communicated to the media that he looks towards the best participation of members and international participants. This will be the first launch of offshore Indian rupee derivatives contract.

 

 

What are liquid funds? Find more

, , 0 Comment
Read More
Equity Right, IRCTC
Business, Economy, IPO research, Market News - October 15, 2019

IRCTC Lists 129% higher than IPO price.

  IRCTC lISTS 129% HIGHER Established in September 1999, The Indian Railway for Catering and Tourism Corporation (IRCTC) has been there for passengers wishing to travel by the trains. IRCTC...
, , , 0 Comment
Read More